Fabenol® is an alpha-amylase inhibitory natural extract obtained from Phaseolus vulgaris (common bean, kidney bean) that blocks the digestion of dietary starch, thereby offering potential benefits in the maintenance of healthy blood sugar levels and optimal body composition.
The emergence of obesity as the leading public health problem in the United States is a matter of great concern. Over 58 million adults in the U.S. are obese and about one in five American children and adolescents is overweight. Obesity greatly increases the risk of premature death, and it is a major risk factor for developing chronic conditions such as diabetes, heart disease, high blood pressure, gallbladder disease, arthritis, lung problems and some of the more common forms of cancer. According to government statistics, obesity accounts for about three hundred thousand premature deaths in the United States each year.
An alpha-amylase inhibitor inhibits the digestion of starch thereby potentially improving postprandial carbohydrate tolerance in people with low glucose tolerance. As excess dietary carbohydrate is metabolized to fat; inhibition of carbohydrate digestion may help in weight management...
Phaseolus vulgaris belongs to the botanical family of Leguminosae. It is a sub-erect or twining annual herb, native of tropical America and now grown extensively throughout the warm regions of the world. The leaves are trifoliate; flowers white to violet-purple; pods slender, 10-26 cm long, straight...
The seeds of Phaseolus vulgaris contain an inhibitor of alpha-amylase. This alpha amylase inhibitor is identified in the protein fraction of the bean. This protein binds with the active sites of alpha- amylase and prevents the starch metabolizing activity; hence it is also called as "Starch Blocker"...